Jun 23, 2020 / 05:30PM GMT
George Farmer - BMO Capital Markets Equity Research - Analyst
Hi. Hello, everyone. Good afternoon. Welcome to our afternoon session of the Virtual BMO Healthcare Conference. I'm George Farmer, Senior Biotechnology Analyst at BMO. It's my pleasure to have the management team of Incyte with us this afternoon, and we're going to talk about company progress. We have with us the CEO, Hervé Hoppenot; and the CFO, Christiana Stamoulis. We're going to have a fireside chat with both of them. Thank you very much for being here.
HervéHoppenot - Incyte Corporation - Chairman, President & CEO
Well, thank you for inviting us.
Questions and Answers:
George Farmer - BMO Capital Markets Equity Research - AnalystYes, wonderful. So perhaps we can just start on a high level and talk about flagship product, Jakafi. You have provided us with some very bullish sales guidance, 2020 sales guidance of $1.88 billion to $1.95 billion this year that you maintained on your quarterly call. Can you tell us about your
Trustpilot
